Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Sender Gary Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 Sender Gary (Director) has filed a Form 4 on Schrodinger, Inc.
Txns: Granted 6,250 shares @ $0
Granted 12,500 options to buy @ $45.26, valued at $565.8k
05/26/2023 4 Sender Gary (Director) has filed a Form 4 on Harmony Biosciences Holdings, Inc.
Txns: Granted 9,613 options @ $35.99, valued at $346k
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/24/2022 4 Sender Gary (Director) has filed a Form 4 on Harmony Biosciences Holdings, Inc.
Txns: Granted 8,726 options @ $41.33, valued at $360.6k
12/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2021 4 Sender Gary (Director) has filed a Form 4 on Harmony Biosciences Holdings, Inc.
Txns: Granted 13,333 options @ $32.5, valued at $433.3k
03/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/01/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/02/2020 4 Sender Gary (CFO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 312 shares @ $0.4955, valued at $154.6
10/16/2020 4 Sender Gary (Director) has filed a Form 4 on iBio, Inc.
Txns: Granted 100,000 options @ $2.05, valued at $205k
10/16/2020 3 Sender Gary (Director) has filed a Form 3 on iBio, Inc.
10/01/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/02/2020 4 Sender Gary (CFO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 312 shares @ $0.6194, valued at $193.3
08/21/2020 4 Sender Gary (CFO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 3,204 shares @ $0.6476, valued at $2.1k
Exercised 11,250 options to buy @ $0
08/20/2020 4 Sender Gary (Director) has filed a Form 4 on Harmony Biosciences Holdings, Inc.
Txns: Granted 16,583 options @ $24, valued at $398k
08/18/2020 3 Sender Gary (Director) has filed a Form 3 on Harmony Biosciences Holdings, Inc.
08/04/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2020 4 Sender Gary (CFO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 312 shares @ $1.14, valued at $355.7
05/04/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/02/2020 4 Sender Gary (CFO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 301 shares @ $0.575, valued at $173.1
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2020 3 Sender Gary (Director) has filed a Form 3 on Schrodinger, Inc.
02/04/2020 4 Sender Gary (CFO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 4,295 shares @ $1.35, valued at $5.8k
08/26/2019 4/A Sender Gary (CFO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Sold 3,390 shares @ $2.08, valued at $7.1k
08/21/2019 4 Sender Gary (CFO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Paid exercise price by delivering 3,390 shares @ $2.08, valued at $7.1k
Exercised 11,250 options to buy @ $0
02/04/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/23/2018 4 Sender Gary (CFO) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Bought 2,000 shares @ $4.57, valued at $9.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy